Jakob Dal

  1. 2020
  2. Published

    Phenotypic and genotypic features of a large kindred with a germline AIP variant. / Dal, Jakob; Nielsen, Eigil H; Klose, Marianne; Feldt-Rasmussen, Ulla; Andersen, Marianne; Vang, Søren; Korbonits, Márta; Jørgensen, Jens Otto L.

    In: Clinical Endocrinology, Vol. 93, No. 2, 08.2020, p. 146-153.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  3. Published

    Fibroblast activation protein is a GH target: A prospective study of patients with acromegaly before and after treatment. / Arlien-Søborg, Mai C; Grøndahl, Camilla; Bæk, Amanda; Dal, Jakob; Alle Madsen, Michael; Høgild, Morten Lyng; Pedersen, Steen B; Bjerre, Mette; Jørgensen, Jens O L.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 105, No. 1, 01.01.2020.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  4. 2019
  5. Published

    Determinants Of The Growth Hormone Nadir During Oral Glucose Tolerance Test In Adults. / Schilbach, Katharina; Gar, Christina; Lechner, Andreas; Nicolay, Shiva Sophia; Schwerdt, Laura; Haenelt, Michael; Dal, Jakob; Jorgensen, Jens Otto L; Störmann, Sylvere; Schopohl, Jochen; Bidlingmaier, Martin.

    In: European Journal of Endocrinology, Vol. 181, No. 1, 2019, p. 55-67.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  6. 2018
  7. Published

    Cancer Incidence in Patients with Acromegaly: A cohort study and meta-analysis of the literature. / Dal, Jakob; Leisner, Michelle Z; Hermansen, Kasper; Farkas, Dóra Körmendiné; Bengtsen, Mads; Kistorp, Caroline; Nielsen, Eigil H; Andersen, Marianne; Feldt-Rasmussen, Ulla; Dekkers, Olaf M; Sørensen, Henrik Toft; Jørgensen, Jens Otto Lunde.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 103, No. 6, 01.06.2018, p. 2182-2188.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  8. Published

    Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: A randomized multicentre study. / Dal, Jakob; Klose, Marianne; Heck, Ansgar; Andersen, Marianne Skovsager; Kistorp, Caroline; Nielsen, Eigil H; Bollerslev, Jens; Feldt-Rasmussen, Ulla; Jorgensen, Jens Otto L.

    In: European Journal of Endocrinology, Vol. 178, No. 1, 01.01.2018, p. 65-74.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  9. 2017
  10. Published

    Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients. / Christiansen Arlien-Søborg, Mai; Trolle, Christian; Alvarson, Elin; Bæk, Amanda; Dal, Jakob; Otto Lunde Jørgensen, Jens.

    In: Endocrine, Vol. 56, No. 3, 06.2017, p. 589-594.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  11. 2016
  12. Published

    Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery versus Somatostatin Analog Treatment. / Dal, Jakob; Lundby Høyer, Katrine; Pedersen, Steen Bønløkke; Erik Magnusson, Nils; Bjerring, Peter; Frystyk, Jan; Møller, Niels; Jessen, Niels; Otto Lunde Jørgensen, Jens.

    In: Endocrinology, Vol. 101, No. 10, 10.2016, p. 3716-3723.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  13. Published

    Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. / Dal, Jakob; Feldt-Rasmussen, Ulla; Andersen, Marianne; Kristensen, Lars Ø; Laurberg, Peter; Pedersen, Lars; Dekkers, Olaf M; Sørensen, Henrik Toft; Jørgensen, Jens Otto Lunde.

    In: European Journal of Endocrinology. Supplement, Vol. 175, No. 3, 09.2016, p. 181-90.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  14. Published

    What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy? / Muhammad, A; van der Lely, A J; O'Connor, R D; Delhanty, P J; Dal, J; Dallenga, A H; Feelders, R A; Janssen, J A M J L; Jorgensen, J O L; Neggers, S J C M M.

    In: European Journal of Endocrinology. Supplement, Vol. 174, No. 5, 05.2016, p. 663-7.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  15. Published

    Glucose and Fat Metabolism in Acromegaly: From Mice Models to Patient Care. / Dal, Jakob; List, Edward O; Jørgensen, Jens Otto Lunde; Berryman, Darlene E.

    In: Neuroendocrinology, Vol. 103, No. 1, 01.02.2016, p. 96-105.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  16. 2015
  17. Published

    An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene. / Dinesen, Pia T; Dal, Jakob; Gabrovska, Plamena; Gaustadnes, Mette; Gravholt, Claus H; Stals, Karen; Denes, Judit; Asa, Sylvia L; Korbonits, Márta; Jørgensen, Jens O L.

    In: Endocrinology, Diabetes & Metabolism Case Reports, Vol. 2015, 2015, p. 140105.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  18. 2014
  19. Published

    Akromegali maskeret af symptomatisk hyperprolaktinæmi. / Dal, Jakob; Steffensen, Maria Charlotte; Hansen, Troels K; Jørgensen, Jens Otto L.

    In: Ugeskrift for Laeger, Vol. 176, No. 1, 06.01.2014.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  20. Published

    Behandling med dopaminagonister og udvikling af hjerteklapsygdom hos patienter med hyperprolaktinæmi. / Steffensen, Maria Charlotte; Mægbæk, Merete Lund; Laurberg, Peter; Andersen, Marianne; Kistorp, Caroline; Nørrelund, Helene; Dal, Jakob; Jørgensen, Jens Otto Lunde.

    In: Ugeskrift for Laeger, Vol. 176, No. 1, 06.01.2014, p. 58-60.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

  21. Published

    Genetisk screening for mutation muliggør tidlig diagnostik af hypofyseadenomer. / Dal, Jakob; Gaustadnes, Mette; Kristensen, Kurt; Gravholt, Claus Højbjerg; Jørgensen, Jens Otto Lunde.

    In: Ugeskrift for Laeger, Vol. 176, No. 1, V09120529, 06.01.2014, p. 54-57.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  22. Published

    Acromegaly according to the Danish National Registry of Patients: how valid are ICD diagnoses and how do patterns of registration affect the accuracy of registry data? / Dal, Jakob; Skou, Nikolaj; Nielsen, Eigil Husted; Jørgensen, Jens Otto Lunde; Pedersen, Lars.

    In: Clinical epidemiology, Vol. 6, 2014, p. 295-9.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  23. 2012
  24. Published

    Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone. / Graversen, Jonas H; Svendsen, Pia; Dagnæs-Hansen, Frederik; Dal, Jakob; Anton, Gabriele; Etzerodt, Anders; Petersen, Mikkel D; Christensen, Peter A; Møller, Holger J; Moestrup, Søren K.

    In: Molecular Therapy, 2012.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review